http://www.unboundmedicine.com/medline/ebm/research/bicalutamideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19921427/full_citation/Reciprocal_regulation_of_ZEB1_and_AR_in_triple_negative_breast_cancer_cells_Graham TR, Yacoub R, Taliaferro-Smith L, et al. 
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. [JOURNAL ARTICLE]
Breast Cancer Res Treat 2009 Nov 18.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19915794/full_citation/Torsades_de_Pointes_induced_by_a_combination_of_garenoxacin_and_disopyramide_and_other_cytochrome_P450_family_3_subfamily_A_polypeptide_4_influencing_drugs_during_hypokalemia_due_to_licorice_Miyamoto K, Kawai H, Aoyama R, et al. 
Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice. [JOURNAL ARTICLE]
Clin Exp Nephrol 2009 Nov 14.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19912210/full_citation/Frequency_of_zoledronic_acid_to_prevent_further_bone_loss_in_osteoporotic_patients_undergoing_androgen_deprivation_therapy_for_prostate_cancer_Wadhwa VK, Weston R, Parr NJ 
Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer. [JOURNAL ARTICLE]
BJU Int 2009 Nov 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19902473/full_citation/Antagonistic_interaction_between_bicalutamide__Casodex_R___and_radiation_in_androgen_positive_prostate_cancer_LNCaP_cells_Quéro L, Giocanti N, Hennequin C, et al. 
Antagonistic interaction between bicalutamide (Casodex(R)) and radiation in androgen-positive prostate cancer LNCaP cells. [JOURNAL ARTICLE]
Prostate 2009 Nov 9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19902465/full_citation/Establishment_and_characterization_of_an_androgen_receptor_dependent_androgen_independent_human_prostate_cancer_cell_line_LNCaP_CS10_Ishikura N, Kawata H, Nishimoto A, et al. 
Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10. [JOURNAL ARTICLE]
Prostate 2009 Nov 9.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19886863/full_citation/Androgen_regulation_of_the_prostatic_tumour_suppressor_NKX3_1_is_mediated_by_its_3'untranslated_region_Thomas MA, Preece DM, Bentel JM 
Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3'untranslated region. [JOURNAL ARTICLE]
Biochem J 2009 Nov 3.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19836827/full_citation/Consolidation_strategies_in_ovarian_cancer:_Observations_for_future_clinical_trials_Sabbatini P, Spriggs D, Aghajanian C, et al. 
Consolidation strategies in ovarian cancer: Observations for future clinical trials. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Oct 15.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19798757/full_citation/Physicochemical_characterization_of_hot_melt_extruded_bicalutamide_polyvinylpyrrolidone_solid_dispersions_Andrews GP, Abudiak OA, Jones DS 
Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. [JOURNAL ARTICLE]
J Pharm Sci 2009 Oct 1.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19796455/full_citation/Dutasteride_and_bicalutamide_in_patients_with_hormone_refractory_prostate_cancer:_The_Therapy_Assessed_by_Rising_PSA__TARP__study_rationale_and_design_Sartor O, Gomella LG, Gagnier P, et al. 
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: The Therapy Assessed by Rising PSA (TARP) study rationale and design. [Journal Article]
Can J Urol 2009 Oct; 16(5):4806-12.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19790238/full_citation/Antiandrogen_withdrawal_syndrome_and_alternative_antiandrogen_therapy_associated_with_the_W741C_mutant_androgen_receptor_in_a_novel_prostate_cancer_xenograft_Terada N, Shimizu Y, Yoshida T, et al. 
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft. [JOURNAL ARTICLE]
Prostate 2009 Sep 29.
Abstract | Full Citation | Find Related Articles